The following clinicians contributed to this briefing:
Philip Newsome, professor of hepatology, University of Birmingham, involving in research studies with the manufacturer of FibroScan, EchoSens.
Jonathan Fallowfield, honorary consultant hepatologist, professor of translational liver research, University of Edinburgh, co-principal investigator and co-author on the Innovate UK funded study (McDonald et al. 2018) and co-investigator for an ongoing study (HepaT1ca, NCT03213314).
Jeremy Cobbold, consultant hepatologist and clinical lead for hepatology, John Radcliffe Hospital, Oxford University Hospital NHS Foundation Trust, in collaboration with the company using LiverMultiScan in clinical research. Co-author on Pavlides et al. 2017.